The study of testing effect of syp.Rubyclin in discoloration and itching of ski
- Conditions
- Health Condition 1: null- Eczema skin disorders redness itching burning
- Registration Number
- CTRI/2018/03/012718
- Lead Sponsor
- Aushadhi Bhavan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
subjects with inflammation redness itching burning in eczema
Subjects with Diabetes Mellitus Type I and uncontrolled Diabetes Mellitus Type II.Known subjects of abnormal thyroid function.Known cases of Severe/Chronic Hepatic or Renal disease.Known subject of any active malignancy.Subjects giving history of significant cardiovascular event < 12 weeks prior to randomization.Subjects ECG demonstrating any signs of uncontrolled arrhythmia / acute ischemia.Lesions of large surface area.Subjects having known chronic, contagious infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV.Subjects using any other investigational drug within 3 days prior to recruitment.Known hypersensitivity to any of the ingredients used in study drug.Pregnant and Lactating femalesSubjects currently participating in any other Clinical studyAny other medical or surgical condition considered unsuitable for subject participation in the study as per Investigator judgment.Subject having H/O keliod formation following skin injury,severe dermatitis requiring systemic corticosteroids
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the effect of syp rubyclin in the eczemabacterial count of infected lesion 10 daysscaling inflammation burning and itching in eczema <br/ ><br>Timepoint: 30 days
- Secondary Outcome Measures
Name Time Method Reduction severity of pruritis in eczemaeczema severity grade on IGA scaleTimepoint: 30 days